Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Evogene Ord News

    0,6789 $ +1,40% +0,0094 $
    In : 0,6328 € | 16:28:09 Uhr Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    ISIN: IL0011050551
    US-Symbol: EVGN
    Typ: Aktie

    Evogene Ord News

    16.04.24 - PR Newswire
    Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
    Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting PR Newswire
    11.04.24 - PR Newswire
    Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
    Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting PR Newswire
    02.04.24 - PR Newswire
    Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
    Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry PR Newswire
    28.03.24 - PR Newswire
    Evogene Announces Filing of Annual Report on Form 20-F
    Evogene Announces Filing of Annual Report on Form 20-F PR Newswire
    20.03.24 - PR Newswire
    Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
    Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification PR Newswire
    19.03.24 - PR Newswire
    Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
    Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing PR Newswire
    13.03.24 - PR Newswire
    Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America
    Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-​Inoculant, in Regenerative Agriculture Initiatives in North America PR Newswire
    07.03.24 - PR Newswire
    Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
    Evogene Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire
    06.03.24 - PR Newswire
    AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
    AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides PR Newswire
    05.03.24 - PR Newswire
    Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties
    Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties PR Newswire
    28.02.24 - PR Newswire
    Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
    Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements PR Newswire
    26.02.24 - PR Newswire
    Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
    Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024 PR Newswire
    22.02.24 - PR Newswire
    AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer
    AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer PR Newswire
    21.02.24 - PR Newswire
    AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
    AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution PR Newswire
    20.02.24 - PR Newswire
    Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide
    Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-​Insecticide PR Newswire
    06.02.24 - PR Newswire
    Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
    Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation PR Newswire
    23.01.24 - PR Newswire
    Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
    Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit PR Newswire
    17.01.24 - PR Newswire
    Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
    Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-​Based Immuno-​Oncology Drug PR Newswire
    21.12.23 - PR Newswire
    Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
    Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024 PR Newswire
    19.12.23 - PR Newswire
    Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
    Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation PR Newswire

    Newssuche

    Videos

    09:30 Uhr +34,15%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »